Double-Dose Fears Prompt Heart Drug Recall

Drug-maker Ethex Corp. has announced a recall of five of its generic heart medications due to concerns some of the pills may contain life-threatening double-doses of active ingredients. Overdoses of the drugs could cause deadly heart arrhythmia, low blood pressure, respiratory failure, and other serious complications. The drug recall is being initiated as a precautionary move and no patient deaths or injuries have been reported, the Food and Drug Administration said.

The generic drugs involved in the recall are:

• Propafenone HCl Tablets 150 mg, 225 mg, and 300 mg

• Isosorbide Mononitrate Extended Release Tablets 30 mg and 60 mg

• Morphine Sulfate Extended Release Tablets 15 mg

• Morphine Sulfate Immediate Release Tablets 15 mg and 30 mg

• Dextroamphetamine Sulfate Tablets 10 mg

The lots involved in the recall were all shipped prior to May 22, 2008, officials said.

Patients who have in their possession drugs involved in the recall are urged to contact their healthcare provider.

No related posts.